![Alzheimer’s disease, frontotemporal dementias, progressive supranuclear palsy, Corticobasal degeneration, Clinical Trial Study](/sites/boxerlab.ucsf.edu/files/styles/testimonial_small/public/201809-UCSF-Adam-Boxer-1568%282%29_2.jpg?itok=CfU6889p)
A Phase 2, Multicenter, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AL001 in Heterozygous Carriers of Granulin or C9ORF72 Mutations Causative of Frontotemporal Dementia (Alector AL001-2)
Please go to ClinicalTrials.gov for more information.